The Future Of
African Healthcare
ACRN is building the first African-led
Clinical Research Network
African Clinical Research Network
Full-lifecycle clinical trial execution, across Africa.
End-to-end execution from Phase I through Phase III — African-led, built for global standards.
ACRN operates as Sponsor, Trial Execution Partner, and Site Network Manager — a single integrated African-led platform.
Current Portfolio
Active Studies
| Study | Phase | Countries | ACRN Role | Status |
|---|---|---|---|---|
| Early-Onset Preeclampsia (EOPE) Maternal Health |
Phase II/III | Rwanda, Nigeria | Trial Execution + Site Network | Enrolling |
| Neonatal Probiotics Trial Neonatology |
Phase III | Multi-country Africa | Sponsor-led | Active |
| HIV Vaccine Trial (GRAdHIVNE1) Infectious Disease |
Phase I | Zimbabwe, South Africa | Sponsor + Trial Execution | Start-up |
| Influenza Vaccine Study Infectious Disease |
Phase II/III | Zimbabwe + Regional | Trial Execution + Site Network | Active |
What We Run
Capabilities
Phase I
First-in-human studies, PK/PD profiling, safety and dose escalation, and intensive safety monitoring in controlled African sites.
Phase II–III
Multi-country, registration-enabling, large-cohort efficacy and confirmatory trials with full regulatory oversight.
Observational & Real-World
Cohort studies, surveillance, and outcomes research across African populations to support global submissions.
What We Offer
Services
Presence
Where We Work
ACRN uses a distributed African delivery model — combining local regulatory expertise, clinical sites, laboratories, and centralised operational oversight.
Zimbabwe
Headquarters & coordination hub
Rwanda, Nigeria, South Africa
Active clinical sites
Kenya, Tanzania, Ghana
Expansion pipeline
"Regulatory strength, scientific leadership, and operational accountability are embedded locally."
Our Difference
Why ACRN
01
Africa-led, Africa-first
02
One platform, every role
03
Regulatory expertise built in
04
Digital & lab infrastructure
Ready to run your next trial in Africa?
Whether you need Phase I feasibility, a Phase III site network, or a global health execution partner — ACRN is ready to support your next study.